메뉴 건너뛰기




Volumn 27, Issue 6, 1997, Pages 1113-1116

Acute hepatitis induced by α-interferon, associated with viral clearance, in chronic hepatitis C

Author keywords

Autoimmune hepatitis; Hepatitis C virus; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA2A INTERFERON; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; PROTHROMBIN; VIRUS RNA;

EID: 0030842328     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80157-2     Document Type: Article
Times cited : (19)

References (19)
  • 1
    • 0026595134 scopus 로고
    • Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia
    • Wandl UB, Kloke O, Nidierle N. Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia. Lancet. 339:1992;123-124.
    • (1992) Lancet , vol.339 , pp. 123-124
    • Wandl, U.B.1    Kloke, O.2    Nidierle, N.3
  • 4
    • 0030923160 scopus 로고    scopus 로고
    • Influence of hepatitis G virus infection on the severity of liver disease and response to interferon alpha in patients with chronic hepatitis C
    • Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon alpha in patients with chronic hepatitis C. Ann Intern Med. 126:1997;874-881.
    • (1997) Ann Intern Med , vol.126 , pp. 874-881
    • Martinot, M.1    Marcellin, P.2    Boyer, N.3    Detmer, J.4    Pouteau, M.5    Castelnau, C.6
  • 6
    • 0026603501 scopus 로고
    • Acute exacerbations of liver disease during interferon alfa therapy for chronic hepatitis C
    • Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbations of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology. 102:1992;1406-1408.
    • (1992) Gastroenterology , vol.102 , pp. 1406-1408
    • Shindo, M.1    Di Bisceglie, A.M.2    Hoofnagle, J.H.3
  • 7
    • 0028146133 scopus 로고
    • Recurrent clinical exacerbations of liver disease during the course of infection with hepatitis C virus
    • Yavorski RT, Smith MA, Sjogren MH, Wang RKH. Recurrent clinical exacerbations of liver disease during the course of infection with hepatitis C virus. Am J Gastroenterol. 89:1994;1235-1237.
    • (1994) Am J Gastroenterol , vol.89 , pp. 1235-1237
    • Yavorski, R.T.1    Smith, M.A.2    Sjogren, M.H.3    Wang, R.K.H.4
  • 8
    • 0028587185 scopus 로고
    • Hepatic injury after interferon alfa therapy for chronic hepatitis C
    • Shimizu Y, Joho S, Watanabe A. Hepatic injury after interferon alfa therapy for chronic hepatitis C. Ann Intern Med. 121:1994;723.
    • (1994) Ann Intern Med , vol.121 , pp. 723
    • Shimizu, Y.1    Joho, S.2    Watanabe, A.3
  • 9
    • 0016819632 scopus 로고
    • Lethality of interferon preparations for newborn mice
    • Gresser I, Tovey MG, Maury C, Chouroulinkov I. Lethality of interferon preparations for newborn mice. Nature. 258:1975;76-78.
    • (1975) Nature , vol.258 , pp. 76-78
    • Gresser, I.1    Tovey, M.G.2    Maury, C.3    Chouroulinkov, I.4
  • 10
    • 0018352913 scopus 로고
    • Interferon induced enzymatic activities and their role in antiviral state
    • Baglioni C. Interferon induced enzymatic activities and their role in antiviral state. Cell. 17:1979;255-264.
    • (1979) Cell , vol.17 , pp. 255-264
    • Baglioni, C.1
  • 11
    • 0026756261 scopus 로고
    • Changes in ultrastructure of hepatocytes and liver tests results before, during, and after treatment with interferon-β In patients with HBeAg-positive chronic active hepatitis
    • Itoh S, Marutani K, Matsuo S. Changes in ultrastructure of hepatocytes and liver tests results before, during, and after treatment with interferon-β in patients with HBeAg-positive chronic active hepatitis. Dig Dis Sci. 37:1992;1260-1267.
    • (1992) Dig Dis Sci , vol.37 , pp. 1260-1267
    • Itoh, S.1    Marutani, K.2    Matsuo, S.3
  • 12
    • 0029127584 scopus 로고
    • Inhibition of mitochondrial betaoxidation as a mechanism of hepatotoxicity
    • Fromenty B, Pessayre D. Inhibition of mitochondrial betaoxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 67:1995;101-154.
    • (1995) Pharmacol Ther , vol.67 , pp. 101-154
    • Fromenty, B.1    Pessayre, D.2
  • 13
    • 0027222630 scopus 로고
    • Biological basis for the clinical use of interferon
    • (suppl.)
    • Dianzani F. Biological basis for the clinical use of interferon. Gut. 34:1993;74-76. (suppl.).
    • (1993) Gut , vol.34 , pp. 74-76
    • Dianzani, F.1
  • 14
    • 0028230046 scopus 로고
    • Hazard of interferon treatment in patients with autoimmune chronic active hepatitis
    • Farhat BA, Johnson PJ, Williams R. Hazard of interferon treatment in patients with autoimmune chronic active hepatitis. J Hepatol. 20:1994;560-561.
    • (1994) J Hepatol , vol.20 , pp. 560-561
    • Farhat, B.A.1    Johnson, P.J.2    Williams, R.3
  • 16
    • 0028148193 scopus 로고
    • Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C
    • Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, et al. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol. 21:1994;199-203.
    • (1994) J Hepatol , vol.21 , pp. 199-203
    • Muratori, L.1    Lenzi, M.2    Cataleta, M.3    Giostra, F.4    Cassani, F.5    Ballardini, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.